| Disease | hartnup disease |
| Comorbidity | C0235974|pancreatic cancer |
| Sentences | 1 |
| PubMedID- 20352216 | Conclusions: second-line chemotherapy with s-1 was tolerated with acceptable toxicity and resulted in a relatively high disease control rate in patients with gemcitabine-resistant advanced pancreatic cancer. |
Page: 1